Lowly Expressed Ribosomal Protein S19 in the Feces of Patients with Colorectal Cancer. (9th January 2012)

• Record Type: Journal Article
• Authors: Chien, Chih-Cheng; Tu, Tien-Chien; Huang, Chi-Jung; Yang, Shung-Haur; Lee, Chia-Long
• Other Names: Amedei A. Academic Editor.; Grösch S. Academic Editor.
• Is Part Of: ISRN gastroenterology. Volume 2012(2012)
• Publication Date: 2012-01-09
• Subjects: Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Digestive organs -- Diseases; Gastroenterology; Gastroenterology; Gastrointestinal Diseases; Fulltext; Internet Resources; Periodicals; Electronic journals; Periodicals; Periodical; 616.3
• DOI: 10.5402/2012/394545
• Languages: English
• ISSNs: 2090-4398

Abstract

Abstract : Colorectal cancer (CRC) has become one of the most common fatal cancers. CRC tumorigenesis is a complex process involving multiple genetic changes to several sequential mutations or molecular alterations. P53 is one of the most significant genes; its mutations account for more than half of all CRC. Therefore, understanding the cellular genes that are directly or indirectly related to p53 is particularly crucial for investigating CRC tumorigenesis. In this study, a p53-related ribosomal protein, ribosomal protein S19 (RPS19), obtained from the feces of CRC patients is evaluated by using specifically quantitative real-time PCR and knocked down in the colonic cell line by gene silencing. This study found that CRC patients with higher expressions of RPS19 in their feces had a better prognosis and consistent expressions of RPS19 and BAX in their colonic cells. In conclusion, the potential mechanism of RPS19 in CRC possibly involves cellular apoptosis through the BAX/p53 pathway, and the levels of fecal RPS19 may function as a prognostic predictor for CRC patients.